Di Cripps is a pharmaceutical physician consulting to both large pharma and biotech companies regarding drug development, patient safety and evidence generation strategy. Whilst projects have covered a wide range of therapeutic areas, Di’s recent focus has been oncology, specifically the development of targeted agents and translationally orientated development plans.